Africa: single-dose HPV vaccine to boost immunisation

The WHO Africa Regional Immunization Technical Advisory Group (RITAG) has urged countries to adopt a single-dose schedule for the Human Papillomavirus Vaccine (HPV) in Africa, in line with the World Health Organization’s (WHO) recommendations in 2022. Cameroon and Cabo Verde have demonstrated adaptability by transitioning to a single-dose regimen and expanding vaccination to include boys. Additionally, the endorsement of a single-dose schedule by National Immunization Technical Advisory Groups (NITAGs) in 16 African countries highlights the importance of streamlined and cost-effective strategies. To accelerate progress, WHO emphasizes a strategic approach that includes political advocacy, comprehensive coordination, resource optimization, multisectoral partnerships, and strengthening health systems.